Nexalin Technology (Nexalin Technology) Additional Paid-In Capital : $80.40 Mil(As of Mar. 2024)

View and export this data going back to 2022. Start your Free Trial

What is Nexalin Technology Additional Paid-In Capital?

Nexalin Technology's quarterly additional paid-in capital increased from Sep. 2023 ($79.49 Mil) to Dec. 2023 ($80.24 Mil) and increased from Dec. 2023 ($80.24 Mil) to Mar. 2024 ($80.40 Mil).

Nexalin Technology's annual additional paid-in capital increased from Dec. 2021 ($69.01 Mil) to Dec. 2022 ($77.82 Mil) and increased from Dec. 2022 ($77.82 Mil) to Dec. 2023 ($80.24 Mil).

Nexalin Technology Additional Paid-In Capital Historical Data

The historical data trend for Nexalin Technology's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nexalin Technology Additional Paid-In Capital Chart

Nexalin Technology Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

Additional Paid-In Capital

63.02

69.01

77.82

80.24

Nexalin Technology Quarterly Data
	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Additional Paid-In Capital	Get a 7-Day Free Trial									77.82	77.91	79.49	80.24	80.40

Nexalin Technology Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital

(Issue Price

Par Value)

Shares Outstanding (Diluted Average)

Nexalin Technology Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of Nexalin Technology's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.

Nexalin Technology (Nexalin Technology) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Nexalin Technology Inc (NAS:NXL) » Definitions » Additional Paid-In Capital

Comparable Companies

Traded in Other Exchanges

N/A

Address

1776 Yorktown, Suite 550, Houston, TX, USA, 77056

Website

https://www.nexalin.com

Nexalin Technology Inc design and develop innovative neurostimulation products to uniquely and effectively help combat the ongoing global mental health epidemic. The company has developed an easy-to-administer medical device referred to as Generation 1 or Gen-1 that utilizes bioelectronic medical technology to treat anxiety and insomnia, without the need for drugs or psychotherapy.

Executives

Marilyn Elson	10 percent owner, officer: Ms. Elson serves as CFO	32 CAMLET COURT, ROSELAND NJ 07068
Rick Morad	director	6331 CHAGRIN RIVER ROAD, BENTLEYVILLE OH 44022
Mark White	director, officer: President/CEO	1776 YORKTOWN STREET, SUITE 550, HOUSTON TX 77056
David Owens	director, officer: Chief Medical Officer	4545 HARRIS TRAIL NW, ATLANTA GA 30327
Alan Kazden	director	3435 CONSUELO DRIVE, CALABASAS CA 91302
Leonard Osser	other: Spouse
Ben Hu	director	7021 EDGERTON ROAD, NORTH ROYALTON OH 44133